Lin, H., Liu, Q., Zeng, X., Yu, W., & Xu, G. (2021). Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: A retrospective study. BMC Cancer.

Lin, Huanyi, Qilong Liu, Xianshang Zeng, Weiguang Yu, and Guixing Xu. "Pembrolizumab With or Without Enzalutamide in Selected Populations of Men With Previously Untreated Metastatic Castration-resistant Prostate Cancer Harbouring Programmed Cell Death Ligand-1 Staining: A Retrospective Study." BMC Cancer 2021.

Lin, Huanyi, et al. "Pembrolizumab With or Without Enzalutamide in Selected Populations of Men With Previously Untreated Metastatic Castration-resistant Prostate Cancer Harbouring Programmed Cell Death Ligand-1 Staining: A Retrospective Study." BMC Cancer 2021.